Our present finding of increased granzyme B + CD8 fraction in NSCLC+COPD patients relative to only NSCLC has also pointed to less inhibited immune responsiveness in advanced NSCLC if associated by COPD. Here, GZMB is linked to non-small cell lung carcinoma.